Status:

COMPLETED

Colchicine in Atrial Fibrillation to Prevent Stroke

Lead Sponsor:

Population Health Research Institute

Conditions:

Atrial Fibrillation

Stroke

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine the feasibility of performing a randomized controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at reducing well validated m...

Detailed Description

Atrial fibrillation (AF), the most common cardiac arrhythmia (with a global burden of 33.5 million affected patients in 2010), is responsible for about 20% of ischemic stroke, a major cause of morbidi...

Eligibility Criteria

Inclusion

  • Patients with atrial fibrillation who has been receiving chronic anticoagulation for at least 3 months.

Exclusion

  • Contraindications to colchicine such as allergy/hypersensitivity,
  • Receiving colchicine or other anti-inflammatory drugs (such as corticosteroids, methotrexate, anti-neoplastic, Interleukin 1-1b antagonist, Tumor necrosis factor-alpha inhibitor),
  • Receiving food or co-medications such as strong-moderate cytochrome P450 3A4 inhibitors that will result in elevated plasma level of colchicine,
  • Inflammatory disorders (SLE, Rheumatoid arthritis, connective tissue disorder) or chronic infection,
  • Severe renal (eGFR\< 30ml/min/1.73m2), or liver failure or liver aminotransferase (ALT/AST \> 2x Upper limit of normal),
  • Moderate or severe cytopenias (platelet \< 100, neutrophil count \< 1.5) or existing blood dyscrasia (e.g., myelodysplasia)
  • Pregnant or lactating woman or woman of child bearing age no protected by reliable contraception.

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 17 2020

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT02282098

Start Date

November 1 2014

End Date

November 17 2020

Last Update

February 23 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hamilton General Hospital

Hamilton, Ontario, Canada, L8L 2X2